
India · Pharmaceuticals startup
Emil Pharmaceutical Industries Pvt.
Funding reportedLast round: Private equity
Follow Emil Pharmaceutical Industries Pvt. Ltd. and see its new rounds in your feed.Start following
Emil Pharmaceutical Industries Pvt.
Ltd. is an Indian pharmaceutical company focused on generic manufacturing. The company collaborates with major global and domestic firms, including Pfizer, Abbott, and Viatris Ltd. Emil operates two manufacturing facilities, with plans for a third by 2025, producing over 3.3 billion tablets and 1.8 billion capsules annually. Their product range includes tablets, capsules, powders, oral liquids, ointments, and gels, covering over 250 formulations across 20 therapeutic categories. Emil offers services in generic pharmaceutical manufacturing and regulatory support for product registrations in Asia, Africa, and CIS countries. The company holds more than 100 registrations globally, showcasing its expertise in regulatory compliance. With a strategic location near Mumbai and advanced manufacturing capabilities, Emil aims to become the largest generics manufacturer in the MIDC, Tarapur, by expanding its production capacity.
Funding, as reported
From Emil Pharmaceutical Industries Pvt. Ltd.'s own website: 2 founders, 3 on the team.
What they build
Known for
health carequality medicinesmultinational clientsmanufacturingformulations developmentmanufacturing of syrups ointmentsregulatory affairspharmaceuticalhospital & health carequality_standardsmedicalgeneric medicinesinhouse quality testingb2chealthcontract manufacturing
Built with from their website
Google MapsGoogle Tag ManagerContact Form 7LiteSpeedWordPress.orgFont AwesomeApacheYouTubeViewport MetaCookieYes
Priority HintsGoogle Font APIMicrosoft ExchangeMySQLPrimeNGMicrosoft 365 Apps & ServicesHostingerMobile Friendly
Add your raise, your deck and your story, and put Emil Pharmaceutical Industries Pvt. Ltd. in front of investors. Or tell us what we have wrong.